Protalix Biotherapeutics
Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.
Total raised
€39M
€39,074,792
Funding rounds
1
Investors
0
distinct backers
Active since
2020-12
latest 2020-12
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-03 | Other | €39M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Trax€791MIsrael · Software
- Oura Health€779MFinland · Healthtech